232 filings
Page 2 of 12
DEFM14A
mrdvst2p7bz74xstlq9
16 May 22
Proxy related to merger
4:08pm
8-K
8do4ig
6 May 22
Sierra Oncology Reports First Quarter 2022 Results
7:05am
PREM14A
1oeag
29 Apr 22
Preliminary proxy related to merger
9:20pm
DFAN14A
842knx2g0h9l9aw oyq
13 Apr 22
Additional proxy materials by non-management
5:16pm
DEFA14A
buo0u
13 Apr 22
Additional proxy soliciting materials
4:04pm
DEFA14A
r8mb2w7h5jo6 1rc
13 Apr 22
Additional proxy soliciting materials
6:11am
8-K
690ceo8c5l5gt22m4g
13 Apr 22
GSK reaches agreement to acquire late-stage biopharmaceutical company Sierra Oncology for $1.9bn
6:09am
8-K
641ih1nayzke00gkqp8i
22 Mar 22
Departure of Directors or Certain Officers
9:35pm
S-8
wst48o
10 Mar 22
Registration of securities for employees
7:45am
8-K
8yjfxj ea
10 Mar 22
Sierra Oncology Reports 2021 Year End Results
7:05am
8-K
5v61cab97j
7 Mar 22
Departure of Directors or Certain Officers
4:15pm
424B5
jrycjrxgecxss92
27 Jan 22
Prospectus supplement for primary offering
5:03pm
8-K
argqn3yktd zjm8
27 Jan 22
Other Events
6:15am
FWP
v2lo6ku5zsvqv0
27 Jan 22
Free writing prospectus
6:06am
424B5
9rykw
25 Jan 22
Prospectus supplement for primary offering
4:31pm
8-K
82w9wgsw86h
25 Jan 22
Entry into a Material Definitive Agreement
4:02pm
EFFECT
cnws0qu
12 Nov 21
Notice of effectiveness
12:00am